Skip to main content

Study M820

Study name

Kim SS 2021

Title

UPLC-MS/MS-based profiling of 31 neurochemicals in the mouse brain after treatment with the antidepressant nefazodone

Overall design

In this study, the authors developed a method for simultaneous analysis of 31 neurochemicals in mouse whole brain tissue using liquid chromatography tandem mass spectrometry (LC-MS/MS). ICR mice were divided into the following 4 groups: (1) single-dose control group (single-dose vehicle treatment), (2) single-dose nefazodone group (single-dose of nefazodone), (3) multiple-dose control group (vehicle treatment for three doses), and (4) multiple-dose nefazodone group (nefazodone treatment for three doses, every 2 h one dose). Nefazodone was administered intraperitoneally injected into mouse at a dose of 100 mg/kg. Brain tissues were collected 1 hour after injection. Five samples per group were used for targeted metabonomic analysis.

Study Type

Type3;

Data available

Unavailable

Organism

Mouse; ICR mouse;

Categories of depression

Healthy individuals; Healthy individuals; Healthy individuals;

Criteria for depression

Not reported

Sample size

20

Tissue

Central; Brain; Brain;

Platform

MS-based; LC-MS: ultra-performance liquid chromatograph (ACQUITY UPLCTM system, Waters Corporation, Milford, MA, USA) with Xevo TQ-S triple quadrupole mass spectrometer (Waters Corporation);

PMID

N/A

DOI

10.1016/j.microc.2021.106580

Citation

Kim SS, Lee H, Song JS, et al. UPLC-MS/MS-based profiling of 31 neurochemicals in the mouse brain after treatment with the antidepressant nefazodone. Microchemical Journal. 2021, 169, 106580.

Metabolite

Gamma-Aminobutyric acid;

L-Phenylalanine;

L-Leucine;

L-Glutamic acid;

L-Tyrosine;

5-Hydroxyindoleacetic acid;

Choline;

L-Kynurenine;

Serotonin;

Hydroxykynurenine;

Betaine;

L-Histidine;

Dopamine;

3-Methoxytyramine;

Acetylcholine;

p-Octopamine;